Joanna Horobin
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Joanna Horobin
Earlier roles on record: Board Member at Kymera Therapeutics, Inc. (KYMR) until June 18, 2024. Kymera Therapeutics, Inc. reported in an 8-K filed June 20, 2024 that Joanna Horobin resigned as member of the Board of Directors, effective June 18, 2024.
“On June 18, 2024, Joanna Horobin, M.B., Ch.B. a member of the Board of Directors (the "Board") of Kymera Therapeutics, Inc. (the "Company") and the Audit Committee of the Board (the "Audit Committee") and Nominating and Corporate Governance Committee of the Board (the "Nominating and Corporate Governance Committee"), notified the Company of her resignation from the Board and all committees thereof, effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2024-06-18
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.